In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vivant Medical Inc.

Division of Medtronic PLC

Latest From Vivant Medical Inc.

Deal Statistics Quarterly, Q3 2005

In this issue, we present another installment of our quarterly review of dealmaking for July-September 2005. Our data comes from Windhover's Strategic Intelligence Systems, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries
BioPharmaceutical Medical Device

Phase II Can Be a Proof-of-Concept for Management, Too

Obtaining proof-of-concept data is often the key inflection point in the life cycle of a compound. How well a biotech anticipates and plans for the transition from one stage of business to the next may similarly be a critical factor in the company's overall success, according to survey of biotech management practices by Mardis, Aibel & Associates.
BioPharmaceutical Strategy

Three Arch Sticks to its Knitting

Three Arch Partners recently raised $400 million in less than a month's time, creating probably the largest pool of venture capital dedicated to medical devices. The fund came together quickly, through existing limited partners. Three Arch told existing investors that it planned to do exactly what has made it successful in the past: focus on medical devices with a smattering of selected services, dedicating a majority of the fund-perhaps 70%--to early stage investments. For investors who have been with Three Arch through its past funds, that works.
Business Strategies

Vivant Medical Inc.

Vivant Medical Inc. has developed minimally invasive microwave ablation technology for solid tumors. Vivant believes that its technology---which includes a novel ring-shaped probe--will be faster, safer and more effective than radiofrequency ablation.
Medical Device
See All

Company Information